Loading…
CONMED Corporation is projected to rise to $45.12 by 2027, a +17% move from its current price of $38.48. CNMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $37.29 | $38.50 | $39.74 | +0.04% |
| Jul 14 | $36.82 | $38.51 | $40.28 | +0.09% |
| Jul 15 | $36.47 | $38.53 | $40.71 | +0.13% |
| Jul 16 | $36.17 | $38.55 | $41.08 | +0.18% |
| Jul 17 | $35.92 | $38.57 | $41.40 | +0.22% |
| Jul 18 | $35.69 | $38.58 | $41.70 | +0.27% |
| Jul 19 | $35.49 | $38.60 | $41.98 | +0.31% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $35.49 | $38.60 | $41.98 | +0.31% |
| Week 2 | $34.38 | $38.72 | $43.61 | +0.62% |
| Week 3 | $33.58 | $38.84 | $44.93 | +0.93% |
| Week 4 | $32.93 | $38.96 | $46.09 | +1.25% |
| Week 5 | $32.38 | $39.08 | $47.16 | +1.56% |
| Week 6 | $31.91 | $39.20 | $48.16 | +1.88% |
| Week 7 | $31.48 | $39.32 | $49.12 | +2.19% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CNMD is the stock ticker for CONMED Corporation, a medical technology company that develops, manufactures, and sells devices and equipment for surgical procedures.
Its orthopedic surgery portfolio includes BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, along with supporting products such as powered resection instruments, fluid management, and visualization systems and related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries.
The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. It was incorporated in 1970 and is headquartered in Largo, Florida.
CNMD is a healthcare stock representing CONMED Corporation, a medical technology company. The current price is $36.69 per share, with a market capitalization of $1.1B and a market rank of 2502.
The forecast implies a gradually higher price path, with 2026 average near $36.69 and 2030 average near $45.73, rising toward $97.30 by 2040 and $145.61 by 2050. The projected maximums reach $68.39 in 2030, $171.59 in 2040, and $283.15 in 2050, with multi-year outlook showing bullish sentiment in the long term. ROI values cited include 0 for 2026, 24.6 for 2030, 165.2 for 2040, and 296.9 for 2050.
A major floor 22.1% below — a decisive break under it would weaken the trend.
The nearest floor, 16.6% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 12.8% above — clearing it would confirm fresh momentum.
Key CNMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CNMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $35.62 | Buy | $36.08 | Buy |
| MA 10 | $34.78 | Buy | $35.24 | Buy |
| MA 20 | $34.33 | Buy | $34.88 | Buy |
| MA 50 | $35.31 | Buy | $35.45 | Buy |
| MA 100 | $37.21 | Buy | $37.05 | Buy |
| MA 200 | $40.12 | Sell | $40.88 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.73 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 251.13 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.47 | Buy |
| ROC (12) | 13.85 | Buy |
| Bollinger %B (20,2) | 1.19 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.13 | Sell |
| Awesome (5,34) | 0.82 | Buy |
| Ultimate (7,14,28) | 74.23 | Sell |
| Momentum (10) | 3.92 | Buy |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 36.50 | Buy |
| ADX (14) | 11.12 | Neutral |
| ATR (14) | 1.17 | Info |
The 30-day technical picture shows bullish sentiment with RSI(14) at 60 and a current price near the mid-range of recent activity. The SMA50 is $35.28 and the SMA200 is $40.18, indicating near-term momentum slightly closer to the shorter moving average than the longer one.
Near-term support is at $32.11 and resistance at $36.90, with the 30-day trading range spanning from $29.89 to $45.04. These levels suggest a trading window where price could gravitate toward the $36.90 resistance or test the supported area near $32.11 before any sustained move.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $32.11 | $38.48 | $50.17 | 0% | Neutral | |
| $35.37 | $45.12 | $61.20 | +17% | Neutral | |
| $33.21 | $43.78 | $61.93 | +14% | Neutral | |
| $33.91 | $45.95 | $67.17 | +19% | Neutral | |
| $35.30 | $49.02 | $73.64 | +27% | Bullish | |
| $33.44 | $47.47 | $73.05 | +23% | Bullish | |
| $42.42 | $61.50 | $96.68 | +60% | Bullish | |
| $48.62 | $71.89 | $115.22 | +87% | Bullish | |
| $45.85 | $69.07 | $112.68 | +80% | Bullish | |
| $47.09 | $72.22 | $119.77 | +88% | Bullish | |
| $64.84 | $107.98 | $191.78 | +181% | Bullish | |
| $84.44 | $162.53 | $318.72 | +322% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $32.11 | $38.48 | $45.76 | +0.00% |
| August 2026 | $32.40 | $38.41 | $46.87 | -0.18% |
| September 2026 | $33.52 | $40.06 | $49.52 | +4.30% |
| October 2026 | $33.65 | $40.50 | $50.61 | +1.10% |
| November 2026 | $32.50 | $39.35 | $49.62 | -2.84% |
| December 2026 | $32.41 | $39.46 | $50.17 | +0.28% |
Click any year to see its month-by-month CNMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CNMD is projected to trade between $32.11 and $50.17, averaging $38.48 — a potential gain of 0% from today's $38.48. A consolidation phase looks the most probable path here.
CONMED Corporation's 2027 outlook centres on $45.12, within a $35.37 to $61.20 range. That is up +17% on the projected 2026 average. That marks a +17% change versus current levels. Price action looks broadly range-bound.
By 2028, CNMD could reach as high as $61.93, with a base case around $43.78 and support toward $33.21 — roughly +14% from $38.48. A consolidation phase looks the most probable path here.
Expect CNMD to range from $33.91 to $67.17 through 2029. The $45.95 average target implies a +19% move from current prices. That is up +5% on the projected 2028 average. Price action looks broadly range-bound.
The CNMD price prediction for 2030 points to an average of $49.02 (low $35.30, high $73.64) — a potential gain of +27% on today's $38.48. Buyers look set to stay in control over this stretch.
In 2031, CNMD is projected to trade between $33.44 and $73.05, averaging $47.47 — a potential gain of +23% from today's $38.48. That is -3% versus the projected 2030 average. Momentum favours further upside here.
CONMED Corporation's 2032 outlook centres on $61.50, within a $42.42 to $96.68 range. That is up +30% on the projected 2031 average. That marks a +60% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CNMD could reach as high as $115.22, with a base case around $71.89 and support toward $48.62 — roughly +87% from $38.48. Momentum favours further upside here.
Expect CNMD to range from $45.85 to $112.68 through 2034. The $69.07 average target implies a +80% move from current prices. That is -4% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
The CNMD price prediction for 2035 points to an average of $72.22 (low $47.09, high $119.77) — a potential gain of +88% on today's $38.48. Momentum favours further upside here.
In 2040, CNMD is projected to trade between $64.84 and $191.78, averaging $107.98 — a potential gain of +181% from today's $38.48. That is up +50% on the projected 2035 average. Buyers look set to stay in control over this stretch.
CONMED Corporation's 2050 outlook centres on $162.53, within a $84.44 to $318.72 range. That is up +51% on the projected 2040 average. That marks a +322% change versus current levels. Momentum favours further upside here.
Investing $1,000 in CNMD today (≈ 25.987526 CNMD) could be worth
$4,223.74
+$3,223.74 (+322%) by 2050 · US Dollar
Based on the average projected CNMD price of $162.53 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CNMDwould be worth at today's price.
$1,000 invested in CNMD on Jul 10, 2025 (≈ 18.667165 CNMD) would be worth
$718.31
-$281.69 (-28.2%) today · 0.72× · US Dollar
Based on a CNMD entry price of $53.57 vs. today's $38.48.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $33.83 | $1,137.45 | +13.7% |
| 1 month ago | $36.3 | $1,060.06 | +6.0% |
| 3 months ago | $36.74 | $1,047.36 | +4.7% |
| 6 months ago | $43.46 | $885.41 | -11.5% |
| 1 year ago | $53.57 | $718.31 | -28.2% |
| All time (5.0y) ago | $132.86 | $289.63 | -71.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CNMD forecast.
Our base-case forecast reaches $77.00 around 2040.
Implied market cap at $77.00: $2.32B
The multi-year forecast points to a meaningful upside path, with the 2030 average at $45.73 and a max of $68.39, implying substantial appreciation from today’s level. The longer horizon shows stronger upside with 2040 averaging $97.30 and 2050 averaging $145.61, and corresponding max values of $171.59 and $283.15, respectively.
Notably, the forecast registers bullish sentiment from 2032 onward, with 2032 average $56.54 and 2033 average $65.91, continuing into 2034 at $63.21 and 2035 at $66.24, all accompanied by rising max values and higher ROI figures (e.g., 54.1 in 2032, 79.7 in 2033, 72.3 in 2034, 80.5 in 2035, 165.2 in 2040, and 296.9 in 2050).
These are estimates, not guarantees, and are subject to market conditions. The forecast highlights substantial upside in the 2030s through the 2050s, but periods of weaker performance can occur alongside broader market shifts.
Tap a question to reveal the answer.
In 2030, the forecast shows a min of $33.07, an average of $45.73, and a max of $68.39, with a forecasted ROI of 24.6 and a bullish sentiment.
The forecast includes positive ROI values across several years (e.g., 2027 16.6, 2028 12.8, 2029 17.9, 2030 24.6, 2032 54.1, 2033 79.7, 2034 72.3, 2035 80.5, 2040 165.2, 2050 296.9) and overall bullish momentum in the longer term, though these are estimates and not guarantees.
Yes. The 2035 forecast shows a max of $109.18, which exceeds $100.
The 2040 average is $97.30, with a max of $171.59 and an estimated ROI of 165.2, in a bullish long-term outlook.
The current price is $36.69, with a market cap of $1.1B and a market rank of 2502.
CONMED Corporation Community Discussion
0Share your CONMED Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.